TY - JOUR
T1 - A reference equation for lung volume on computed tomography in Japanese middle-aged and elderly adults
AU - Tanabe, Naoya
AU - Sato, Susumu
AU - Shimada, Takafumi
AU - Kaji, Shizuo
AU - Shiraishi, Yusuke
AU - Terada, Satoru
AU - Maetani, Tomoki
AU - Mochizuki, Fumi
AU - Shimizu, Kaoruko
AU - Suzuki, Masaru
AU - Chubachi, Shotaro
AU - Terada, Kunihiko
AU - Tanimura, Kazuya
AU - Sakamoto, Ryo
AU - Oguma, Tsuyoshi
AU - Sato, Atsuyasu
AU - Kanasaki, Megumi
AU - Muro, Shigeo
AU - Masuda, Izuru
AU - Iijima, Hiroaki
AU - Hirai, Toyohiro
N1 - Publisher Copyright:
© 2023
PY - 2024/1
Y1 - 2024/1
N2 - Background: Effective use of lung volume data measured on computed tomography (CT) requires reference values for specific populations. This study examined whether an equation previously generated for multiple ethnic groups in the United States, including Asians predominantly composed of Chinese people, in the Multi-Ethnic Study of Atherosclerosis (MESA) could be used for Japanese people and, if necessary, to optimize this equation. Moreover, the equation was used to characterize patients with chronic obstructive pulmonary disease (COPD) and lung hyperexpansion. Methods: This study included a lung cancer screening CT cohort of asymptomatic never smokers aged ≥40 years from two institutions (n = 364 and 419) to validate and optimize the MESA equation and a COPD cohort (n = 199) to test its applicability. Results: In all asymptomatic never smokers, the variance explained by the predicted values (R2) based on the original MESA equation was 0.60. The original equation was optimized to minimize the root mean squared error (RMSE) by adjusting the scaling factor but not the age, sex, height, or body mass index terms of the equation. The RMSE changed from 714 ml in the original equation to 637 ml in the optimized equation. In the COPD cohort, lung hyperexpansion, defined based on the 95th percentile of the ratio of measured lung volume to predicted lung volume in never smokers (122 %), was observed in 60 (30 %) patients and was associated with centrilobular emphysema and air trapping on inspiratory/expiratory CT. Conclusions: The MESA equation was optimized for Japanese middle-aged and elderly adults.
AB - Background: Effective use of lung volume data measured on computed tomography (CT) requires reference values for specific populations. This study examined whether an equation previously generated for multiple ethnic groups in the United States, including Asians predominantly composed of Chinese people, in the Multi-Ethnic Study of Atherosclerosis (MESA) could be used for Japanese people and, if necessary, to optimize this equation. Moreover, the equation was used to characterize patients with chronic obstructive pulmonary disease (COPD) and lung hyperexpansion. Methods: This study included a lung cancer screening CT cohort of asymptomatic never smokers aged ≥40 years from two institutions (n = 364 and 419) to validate and optimize the MESA equation and a COPD cohort (n = 199) to test its applicability. Results: In all asymptomatic never smokers, the variance explained by the predicted values (R2) based on the original MESA equation was 0.60. The original equation was optimized to minimize the root mean squared error (RMSE) by adjusting the scaling factor but not the age, sex, height, or body mass index terms of the equation. The RMSE changed from 714 ml in the original equation to 637 ml in the optimized equation. In the COPD cohort, lung hyperexpansion, defined based on the 95th percentile of the ratio of measured lung volume to predicted lung volume in never smokers (122 %), was observed in 60 (30 %) patients and was associated with centrilobular emphysema and air trapping on inspiratory/expiratory CT. Conclusions: The MESA equation was optimized for Japanese middle-aged and elderly adults.
KW - Healthy
KW - Imaging
KW - Normal
KW - Total lung capacity
KW - Total lung volume
UR - http://www.scopus.com/inward/record.url?scp=85179991328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179991328&partnerID=8YFLogxK
U2 - 10.1016/j.resinv.2023.12.004
DO - 10.1016/j.resinv.2023.12.004
M3 - Article
C2 - 38101279
AN - SCOPUS:85179991328
SN - 2212-5345
VL - 62
SP - 121
EP - 127
JO - Respiratory Investigation
JF - Respiratory Investigation
IS - 1
ER -